Cleared Traditional

K222006 - Sclerotherapy & Endoscopic Needles (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222006 · G-Flex Europe Sprl · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
270d
Days
Class 2
Risk

K222006 is an FDA 510(k) clearance for the Sclerotherapy & Endoscopic Needles. Classified as Endoscopic Injection Needle, Gastroenterology-urology (product code FBK), Class II - Special Controls.

Submitted by G-Flex Europe Sprl (Nivelles, BE). The FDA issued a Cleared decision on April 3, 2023 after a review of 270 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1500 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all G-Flex Europe Sprl devices

Submission Details

510(k) Number K222006 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2022
Decision Date April 03, 2023
Days to Decision 270 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
140d slower than avg
Panel avg: 130d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FBK Endoscopic Injection Needle, Gastroenterology-urology
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Inserted Through Endoscope For Injection Of A Solution, Gas, Or Implantable Materials Into Gi Or Gu Tissue.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FBK Endoscopic Injection Needle, Gastroenterology-urology

All 86
Devices cleared under the same product code (FBK) and FDA review panel - the closest regulatory comparables to K222006.
Disposable Endoscopic Injection Needles
K252021 · Changzhou New Med Micro-Medtech Co., Ltd. · Dec 2025
Injector Force Max Single Use Injector (NM-400L)
K252247 · Olympus Medical Systems Corporation · Oct 2025
EzVu Visual Vasopressor injector (EV-19)
K241595 · Veol Medical Technologies Pvt , Ltd. · Feb 2025
Endoscopic Injection Needles
K240675 · Promisemed Hangzhou Meditech Co., Ltd. · Oct 2024
injeTAK Adjustable Tip Needle (DIS199
K241523 · Laborie Medical Technologies, Corp. · Aug 2024
Disposable Injection Needles
K232200 · Ningbo Xinwell Medical Technology Co., Ltd. · Apr 2024